Home › Funds › LETKO, BROSSEAU & ASSOCIATES INC › ABBV

LETKO, BROSSEAU & ASSOCIATES INC position in ABBV

ABBVIE INC · Health Care

LETKO, BROSSEAU & ASSOCIATES INC reported holding 264,679 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$69.2M, representing 1.00% of its reported portfolio and ranking #40 among its reported holdings. LETKO, BROSSEAU & ASSOCIATES INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)264.68K sh
Reported value held$69.24M
Portfolio Weight1.00%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LETKO, BROSSEAU & ASSOCIATES INC's ABBV position evolved

LETKO, BROSSEAU & ASSOCIATES INC first disclosed a stake in ABBV in Q3 2023 at 340,744 shares (US$50.8M). The position peaked in Q3 2026 at 264,679 shares, worth US$69.2M. Across 13 filings, LETKO, BROSSEAU & ASSOCIATES INC increased the stake 0 time(s), trimmed it 12 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 264,679 shares valued at US$69.2M — a reduction of -5,330 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 340.74K $50.79M New
Q4 2023 335.63K $52.01M Reduce
Q1 2024 326.73K $59.50M Reduce
Q2 2024 318.83K $54.69M Reduce
Q3 2024 316.83K $62.57M Reduce
Q4 2024 314.46K $55.88M Reduce
Q1 2025 299.64K $62.78M Reduce
Q2 2025 296.98K $55.13M Reduce
Q3 2025 290.91K $67.36M Reduce
Q4 2025 285.10K $65.14M Reduce
Q1 2026 275.15K $59.84M Reduce
Q2 2026 270.01K $67.95M Reduce
Q3 2026 264.68K $69.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has LETKO, BROSSEAU & ASSOCIATES INC held ABBV?

LETKO, BROSSEAU & ASSOCIATES INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LETKO, BROSSEAU & ASSOCIATES INC's current position in ABBV?

As of Q3 2026, LETKO, BROSSEAU & ASSOCIATES INC holds 264.68K shares of ABBV (ABBVIE INC), valued at $69.24M, representing 1.00% of its reported portfolio and ranking #40.

Has LETKO, BROSSEAU & ASSOCIATES INC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), LETKO, BROSSEAU & ASSOCIATES INC reduced its position in ABBV. The position peaked in Q3 2026 at 264.68K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.